MedKoo Cat#: 407903 | Name: MDK-7103

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MDK-7103 is a MATA2 inhibitor that are useful as therapeutic agents for treating malignancies. MDK-7103 was reported in (US 20180079753 A1 20180322 and WO 2018045071 A1 20180308) MDK-7103 has no formal name. MDK-7103 has CAS#2201057-10-3. For the convenience of scientific communication, we temporally name it as MDK-7103. The last 4 digit of its CAS# was used in its name.

Chemical Structure

MDK-7103
MDK-7103
CAS#2201057-10-3

Theoretical Analysis

MedKoo Cat#: 407903

Name: MDK-7103

CAS#: 2201057-10-3

Chemical Formula: C31H22N6OS

Exact Mass: 526.1576

Molecular Weight: 526.62

Elemental Analysis: C, 70.70; H, 4.21; N, 15.96; O, 3.04; S, 6.09

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
MDK-7103; MDK7103; MDK 7103;
IUPAC/Chemical Name
6-(2-methylbenzo[d]thiazol-6-yl)-2,3-diphenyl-5-(pyridin-2-ylamino)pyrazolo[1,5-a]pyrimidin-7(4H)-one
InChi Key
ZTNQNZDNHUAVEI-UHFFFAOYSA-N
InChi Code
InChI=1S/C31H22N6OS/c1-19-33-23-16-15-22(18-24(23)39-19)27-29(34-25-14-8-9-17-32-25)35-30-26(20-10-4-2-5-11-20)28(36-37(30)31(27)38)21-12-6-3-7-13-21/h2-18,35H,1H3,(H,32,34)
SMILES Code
O=C1C(C2=CC=C3N=C(C)SC3=C2)=C(NC4=NC=CC=C4)NC5=C(C6=CC=CC=C6)C(C7=CC=CC=C7)=NN15
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 526.62 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Pyrazolo[1,​5-​a]​pyrimidin-​7(4H)​-​ones as inhibitors of cellular metabolic processes and their preparation By Konteatis, Zenon D.; Sui, Zhihua; Travins, Jeremy M.; Ye, Zhixiong From U.S. Pat. Appl. Publ. (2018), US 20180079753 A1 20180322. | Language: English, Database: CAPLUS 2. Preparation of pyrazolo[1,​5-​a]​pyrimidin-​7(4H)​-​ones as methionine adenosyltransferase 2A inhibitors for treatment of cancer By Konteatis, Zenon D.; Sui, Zhihua; Travins, Jeremy M.; Ye, Zhixiong From PCT Int. Appl. (2018), WO 2018045071 A1 20180308. | Language: English, Database: CAPLUS